🔎 Trials Near Me

Akèy › Veri

Etid klinik pou Veri ap rekrite nan Etazini

5 etid pou Veri ap rekrite patisipan nan sit atravè Etazini.

Pa eta

Etid ki fèk mete ajou

Tèks ofisyèl etid la (Anglè)

Cantharidin Application in Patients With Common Warts (Verruca Vulgaris) (COVE-3)

Ap rekriteFaz 3
Laj 2 ak plis · Tout sèks · Mizajou Sep 3, 2026 · NCT07637734

Etiology, Pathogenesis, and Natural History of Idiopathic CD4+ Lymphocytopenia

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Aug 31, 2026 · NCT00867269

Long-Term Follow-up Study of Cantharidin (YCANTH [VP-102/TO-208]) in Patients With Common Warts (Verruca Vulgaris)

Ap rekriteFaz 3
Laj 2 ak plis · Tout sèks · Mizajou May 5, 2026 · NCT07457918

Cantharidin Application in Patients With Common Warts (Verruca Vulgaris) (COVE-2)

Ap rekriteFaz 3
Laj 2 ak plis · Tout sèks · Mizajou Jan 21, 2026 · NCT07246590

Human Papillomavirus (HPV) Vaccination vs. Placebo for the Treatment of Refractory Cutaneous Warts

Ap rekriteFaz 2/3
Laj 18 ak plis · Tout sèks · Mizajou Apr 5, 2024 · NCT05625633

Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.